BC Platforms GeneVision
BC Platforms has launched GeneVision software-as-a-service for precision medicine. GeneVision uses the Microsoft Genomics service, which runs on Microsoft Azure, to run several of BC Platforms' existing pipeline technologies to offer scalable, easy-to-use workflows for genotyping and next-generation sequencing, data quality monitoring, and patient report generation starting from raw genome data.
Pacific Biosciences New Polymerase, Software Release
Pacific Biosciences has launched a new polymerase and a new version of its software for its Sequel instrument. The upgrades increase throughput and performance of the Sequel in applications such as de novo assembly, structural variant detection, targeted sequencing, and RNA sequencing. They enable a throughput of 10 gigabases per SMRT cell for long-insert genomic libraries and up to 20 gigabases per SMRT cell for targeted and RNA sequencing applications.
The new release also improves the sensitivity of Iso-Seq, PacBio's RNA sequencing method, while software enhances help simplify the analytics for multiplexed samples, according to the company.
Baylor Genetics ClariFind
Baylor Genetics has launched ClariFind, a somatic tumor next-generation sequencing test that analyzes alterations in 277 cancer genes for both solid tumors and hematologic malignancies. The test uses molecular indexing prior to PCR and sequencing to enable the detection of low-frequency mutations. The ClariFind report provides annotated genomic findings, any associated targeted therapies and available clinical trials, and an interpretative summary.
For more new products and services, please visit the New Products page on our website.